Point72 Asset Management
ABBV icon

Point72 Asset Management’s AbbVie ABBV Stock Holding History

Point72 Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.89M Sell
22,500
-6,800
-23% -$1.51M 0.01% 1717
2025
Q4 		$6.69M Buy
+29,300
New +$6.67M 0.01% 1612
2025
Q2 		– Sell
-70,000
Closed -$14.7M – 2127
2025
Q1 		$14.7M Buy
+70,000
New +$13.6M 0.03% 543
2021
Q2 		– Sell
-100,000
Closed -$10.8M – 943
2021
Q1 		$10.8M Buy
+100,000
New +$10.7M 0.05% 408
2018
Q4 		– Sell
-187,900
Closed -$17.8M – 925
2018
Q3 		$17.8M Buy
+187,900
New +$17.8M 0.07% 329

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management's ABBV Position: Q4 2025 in Review

Point72 Asset Management sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 359,444 shares — an estimated $81.9M sold.

Point72 Asset Management first reported a position in ABBV in Q3 2014 and held it in 19 quarters. The position peaked at $164M in Q1 2023. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Point72 Asset Management reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Point72 Asset Management sold 359,444 AbbVie shares in Q4 2025, an estimated $81.9M.
  • Point72 Asset Management first reported a position in AbbVie in Q3 2014 and held it in 19 quarters.
  • Point72 Asset Management's AbbVie position peaked at $164M in Q1 2023.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Point72 Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.